If it is only 24 cents per share
then MYX has paid too much
.
I think there is ome thing big missing in the calculations of the analyst.
May be analysts is a non sales and marketing pharma man . When a unique product hits the market it takes it like a storm and 50-60% market share is gone and many competitors become obsolewte.
Same will happen here in 10 billion combined market in USA for E4 contraceive and HRT.
News Summary *DJ Mayne Pharma Initiated with A$0.75/Share Price Target by Canaccord Genuity, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.99 |
Change
-0.090(1.77%) |
Mkt cap ! $405.4M | |||
| Open | High | Low | Value | Volume |
| $5.08 | $5.10 | $4.95 | $409.5K | 81.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9795 | $4.98 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.00 | 73 | 6 |
View Market Depth
| Last trade - 14.04pm 30/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |